Company Filing History:
3 out of 1,248 
1 out of 1 
1 out of 52 Years Active: 2001-2005
Title: The Innovative Mind of Anton Egbert Peter Adang in Eindhoven, NL
Introduction
Anton Egbert Peter Adang is a notable inventor based in Eindhoven, Netherlands, recognized for his contributions to the field of chemical compounds and their applications in reproductive health. With a robust portfolio of 5 patents, Adang has made significant strides in developing solutions for fertility regulation and hormone-dependent disorders.
Latest Patents
Among his latest patents, Adang has developed bisaryl derivatives with FSH modulatory activity. This invention relates to compounds characterized by specific formulas aimed at controlling fertility, providing contraception alternatives, and treating hormone-dependent disorders. An example of his innovative work is the compound (3S,6S)-1-N-(7-phenylheptyl)-3-(4-(3,4,5-trimethoxyphenyl)benzyl)-4-N-methyl-6-methyl-2,5-dioxo-1,4-piperazine.
Another significant patent is focused on bicyclic heteroaromatic compounds that serve as LH agonists. These compounds activate LH receptors, demonstrating potential in fertility-regulating therapies. Both patents exemplify Adang's commitment to advancing reproductive health through innovative chemical solutions.
Career Highlights
Throughout his professional journey, Anton Egbert Peter Adang has worked with renowned companies, including Akzo Nobel N.V. and Akzo Nobel. His experience in these organizations has contributed to his expertise in the development of pharmaceuticals and innovative compounds.
Collaborations
Adang has collaborated with talented professionals, including Gerritdina Geziena Gerritsma and Nicole Corine Renée Van Straten. These partnerships have played a pivotal role in driving forward his inventive projects and ensuring successful outcomes in their respective fields.
Conclusion
In conclusion, Anton Egbert Peter Adang is a prominent figure in the realm of innovation, primarily focused on chemical solutions for fertility and hormone-related health issues. His extensive patent portfolio and collaborative efforts underscore his dedication to advancing scientific knowledge and improving health outcomes for many.